SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
FDA
The Day In Review: Neurochem, Inc. Climbs On Approvable Letter
August 14, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Gilead Sciences (Foster City, CA) Pays $365 Million For Corus Pharma, Inc.
July 20, 2006
 · 
1 min read
BioCapital
All-In-One Pill For HIV
July 10, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Anti-Smoking Drug Chantix Gets Approved
May 11, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Abraxis BioScience, Inc. Signs Deal With AstraZeneca PLC
April 27, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Drug, Settles Patent
April 13, 2006
 · 
1 min read
Biotech Bay
Gilead Sciences (Foster City, CA) Won’t Tout AIDS Pill As Preventive
March 30, 2006
 · 
1 min read
Drug Development
AIDS Drugs Show Prevention Promise
March 28, 2006
 · 
1 min read
Biotech Bay
Nothing Like A Room Full Of Brainiacs To Make A Columnist Feel Small
November 21, 2005
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Gilead Sciences, Inc. Announces Second Quarter 2013 Financial Results
July 26, 2013
 · 
1 min read
Business
Gilead Sciences, Inc. to Release Second Quarter 2013 Financial Results on Thursday, July 25, 2013
July 19, 2013
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc. to Present at the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18
June 18, 2013
 · 
1 min read
Drug Development
Gilead Sciences, Inc. Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin’s Lymphoma
June 17, 2013
 · 
1 min read
BioMidwest
AbbVie: We Can Win Race Against Gilead Sciences, Inc. for First New Hepatitis C Drugs
June 14, 2013
 · 
1 min read
Drug Development
Gilead Sciences, Inc.'s Viread Reduces HIV Risk for Drug Users in Study
June 13, 2013
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc. to Present at the Goldman, Sachs & Co. 34th Annual Healthcare Conference on Tuesday, June 11
June 11, 2013
 · 
1 min read
Policy
Gilead Sciences, Inc. Announces FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C
June 10, 2013
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc. to Present at the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29
May 29, 2013
 · 
1 min read
FDA
European Commission (EC) Approves Gilead Sciences, Inc.'s Stribild as Single Tablet Regimen for HIV-1 Treatment
May 28, 2013
 · 
8 min read
Load More